Clinical Trial Detail

NCT ID NCT01703390
Title Biomarker Directed Treatment in Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Arbeitsgemeinschaft medikamentoese Tumortherapie
Indications

colorectal cancer

Therapies

Cetuximab + Fluorouracil + Leucovorin + Oxaliplatin

Cetuximab + Fluorouracil + Irinotecan + Leucovorin

Age Groups: adult senior

No variant requirements are available.